Frontiers The Rise of Non-Tuberculosis Mycobacterial Lung Disease
4.9 (767) · € 17.99 · En Stock
PDF) Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs
Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality - ScienceDirect
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
Frontiers Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?
PDF) A New Single Gene Differential Biomarker for Mycobacterium tuberculosis Complex and Non-tuberculosis Mycobacteria
Frontiers The Impact of Nontuberculous Mycobacteria Species on Mortality in Patients With Nontuberculous Mycobacterial Lung Disease
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review - ScienceDirect
Center for Nontuberculous Mycobacteria and Bronchiectasis
Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection, BMC Medicine
Antibiotics, Free Full-Text
What are Non-tuberculous Mycobacteria?
Frontiers Global Environmental Nontuberculous Mycobacteria and Their Contemporaneous Man-Made and Natural Niches
/product/32/377402/1.jpg?3525)
